These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26537906)

  • 1. BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.
    Afaneh C; Zoghbi V; Finnerty BM; Aronova A; Kleiman D; Ciecierega T; Crawford C; Fahey TJ; Zarnegar R
    Surg Endosc; 2016 Aug; 30(8):3454-60. PubMed ID: 26537906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early referral for esophageal pH monitoring is more cost-effective than prolonged empiric trials of proton-pump inhibitors for suspected gastroesophageal reflux disease.
    Kleiman DA; Beninato T; Bosworth BP; Brunaud L; Ciecierega T; Crawford CV; Turner BG; Fahey TJ; Zarnegar R
    J Gastrointest Surg; 2014 Jan; 18(1):26-33; discussion 33-4. PubMed ID: 24214090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impedance-pH monitoring on medications does not reliably confirm the presence of gastroesophageal reflux disease in patients referred for antireflux surgery.
    Ward MA; Dunst CM; Teitelbaum EN; Halpin VJ; Reavis KM; Swanström LL; DeMeester SR
    Surg Endosc; 2018 Feb; 32(2):889-894. PubMed ID: 28779252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term wireless pH monitoring of the distal esophagus: prolonging the test beyond 48 hours is unnecessary and may be misleading.
    Capovilla G; Salvador R; Spadotto L; Voltarel G; Pesenti E; Perazzolo A; Nicoletti L; Merigliano S; Costantini M
    Dis Esophagus; 2017 Oct; 30(10):1-8. PubMed ID: 28859392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drawbacks of the Current Algorithm for Patients With Symptoms of Gastroesophageal Reflux Disease and the Impact of Adding Wireless pH Study to the Initial Diagnostic Endoscopy: Data From High-Volume Rural Antireflux Center.
    Fanous MY; Hughes T
    Am Surg; 2020 May; 86(5):422-428. PubMed ID: 32684031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.
    Carroll TL; Werner A; Nahikian K; Dezube A; Roth DF
    Laryngoscope; 2017 Oct; 127 Suppl 6():S1-S13. PubMed ID: 28842999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timely confirmation of gastro-esophageal reflux disease via pH monitoring: estimating budget impact on managed care organizations.
    Lee WC; Yeh YC; Lacy BE; Pandolfino JE; Brill JV; Weinstein ML; Carlson AM; Williams MJ; Wittek MR; Pashos CL
    Curr Med Res Opin; 2008 May; 24(5):1317-27. PubMed ID: 18377705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24-h multichannel intraluminal impedance-pH monitoring may be an inadequate test for detecting gastroesophageal reflux in patients with mixed typical and atypical symptoms.
    Han MS; Lada MJ; Nieman DR; Tschoner A; Peyre CG; Jones CE; Watson TJ; Peters JH
    Surg Endosc; 2015 Jul; 29(7):1700-8. PubMed ID: 25398192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort.
    Ang D; Teo EK; Ang TL; Ong J; Poh CH; Tan J; Fock KM
    J Dig Dis; 2010 Feb; 11(1):19-27. PubMed ID: 20132427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of wireless pH-monitoring of gastro-esophageal reflux in children before and after proton pump inhibitors.
    Boström M; Thorsson O; Toth E; Agardh D
    BMC Gastroenterol; 2014 Dec; 14():3. PubMed ID: 25539736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Additional Role of Symptom-Reflux Association Analysis of Diagnosis of Gastroesophageal Reflux Disease Using Bravo Capsule pH Test].
    Jung K; Park MI; Park SJ; Moon W; Kim SE; Kim JH
    Korean J Gastroenterol; 2017 Oct; 70(4):169-175. PubMed ID: 29060954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
    Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
    Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
    Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.